Learning Outcomes:
The learning objectives of the Biomedical Diagnostics module should enable you to:
1. Develop an appreciation of how omics technologies are identifying new diagnostic biomarkers for health assessment and disease status in humans and animals.
2. Understand the role that biomedical diagnostics approaches play in drug development and translational medicine, such as in the use of companion biomarkers for optimal drug selection.
3. Describe the development process from clinical observation/scientific research and clinical trials through to the application of the biomedical diagnostic assays in patients.
4. Gain a comprehensive insight into the general technological framework underlying the biomedical diagnostics industry, with emphasis on more recent developments.
5. Analyze the role and potential of companion biomarkers in the biomedical diagnostics sphere.
6. Describe the core issues, challenges and contributors associated with the development, use, and commercialization of biomedical diagnostic assays.
7. To undertake a presentation on developments in new biomedical diagnostics (continuous assessment via the individual project presentation).
Indicative Module Content:
The following topics are covered within this module:
- The role of biomarkers in disease detection and management
- The principles of medical diagnosis, screening and monitoring
- Omics approaches used in biomarker discovery
- The application of biomedical diagnostics in translational medicine
- Principles of design and production in the diagnostics Industry
- Economics, ethics, IP, and legislation affecting biomedical diagnostics (and associated devices)
- Several case studies of biomedical diagnostics encompassing oncology, toxicology, and digital pathology
-Case studies of companion biomarkers in oncology
- Case studies of non-invasive biomarkers and their associated biomedical devices in health monitoring and disease treatment and management
- Some lecture topics will be complemented by workshops on areas such as evolution of clinical trials and the overall regulatory domain
-There will also be Industry presentations on their biomedical diagnostics and devices (e.g., Oncoassure, Biosensia)